DEAD

Serial Number

98323695

Owner

Boston Pharmaceuticals, Inc.

Attorney

Camille M. Miller

Filing Date

Dec 20, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

KATAMARYN Trademark

Serial Number: 98323695

KATAMARYN is a trademark filed by Boston Pharmaceuticals, Inc. on December 20, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Boston Pharmaceuticals, Inc. (8 trademarks)

55 Cambridge Parkway, Suite 400
Cambridge, MA 02142

Entity Type: 03

Legal Representation

Attorney of Record

Camille M. Miller

6,739 trademarks filed View all →

Correspondence Address

Camille M. Miller Cozen O'Connor

1650 Market Street, Suite 2800

One Liberty Place

Philadelphia, PA 19103

United States

Trademark Details

Filing Date

December 20, 2023

Registration Date

Not Registered

Published for Opposition

February 11, 2025

Goods & Services

Research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Nov 10, 2025 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Nov 10, 2025 ABN6

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 8, 2025 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 11, 2025 NPUB

PUBLISHED FOR OPPOSITION

Feb 11, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 5, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 19, 2025 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 17, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 17, 2025 CRFA

ASSIGNED TO LIE

Jan 17, 2025 ALIE

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Dec 23, 2024 ERSI

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

May 24, 2024 GNS3

LETTER OF SUSPENSION E-MAILED

May 24, 2024 GNSL

SUSPENSION LETTER WRITTEN

May 24, 2024 CNSL

ASSIGNED TO EXAMINER

May 23, 2024 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Apr 13, 2024 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 13, 2024 NWOS

NEW APPLICATION ENTERED

Dec 20, 2023 NWAP

Related Trademarks

More from this Owner

Serial #98323680

BOSTON PHARMACEUTICALS

Serial #98323680

More in Same Class

PATH PILOT

HUO

BOSTON BIOTECH

DOLABRA DIGITAL

BOSTON PHARMACEUTICALS

ZNO CLOUD